Empirical Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Empirical Asset Management's BMY Position: Q2 2026 in Review
Empirical Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 3,364 shares — an estimated $204K sold.
Empirical Asset Management first reported a position in BMY in Q1 2025 and held it in 2 quarters. The position peaked at $264K in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Empirical Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Empirical Asset Management sold 3,364 Bristol-Myers Squibb shares in Q2 2026, an estimated $204K.
- Empirical Asset Management first reported a position in Bristol-Myers Squibb in Q1 2025 and held it in 2 quarters.
- Empirical Asset Management's Bristol-Myers Squibb position peaked at $264K in Q1 2025.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Empirical Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.